Excessive daytime sleepiness, new treatment available in Italy
A new drug is available in Italy, pitolisant (Ozawade *), indicated to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with obstructive sleep apnea (Osa) in whom EDS has been unsatisfactorily treated by primary therapy for sleep apnea, such as continuous positive airway pressure (CPAP) or in which such therapy has not … Read more